Brussels has opened an antitrust probe into Google’s use of publishers’ articles and YouTube uploads for AI, investigating compensation and access rules for creators.

University of Utah researchers developed a bionic hand with AI and sensors for an intuitive grip, improving user experience and reducing cognitive load. The hand's AI can predict finger positions for gripping objects.

Two businessmen have been arrested for smuggling advanced AI technology to China, violating U.S. export controls, with one pleading guilty to exporting NVIDIA GPUs worth $160 million.

New York celebrates the completion of NanoFab Reflection, a key part of a $1 billion investment in semiconductor innovation, expected to create jobs and attract private investment.

NYC Mayor Eric Adams directs city agencies to adopt language tech, enhancing accessibility for non-English speakers, with the NYPD and public schools developing custom apps. The initiative aligns with broader tech strategies for city inclusivity.

FirstNet and AT&T have stationed 14 new deployable cell assets across Hawaii, tripling the local fleet and promising faster restoration of critical communications.

A DOE‑lab ETIPP report finds shallow geothermal and seawater cooling could cool Oahu buildings and ease peak energy demand.

Alexander Khalessi will lead UC San Diego Health’s AI and technology strategy while remaining a clinical leader. The appointment aims to scale pilots into systemwide tools.

A Ninth Circuit panel in San Francisco upheld a TRO blocking OpenAI and Jony Ive from using 'io' to market hardware similar to startup iyO's voice‑only computer.

New training in Hawaii, starting January 12, 2026, aims to prepare residents for unionized jobs in creative industries by teaching safety and equipment use.

Keck‑led researchers used KCWI, JWST, HST and VLT to measure H0 to ~4.5% precision using lensed quasars — and the new number deepens the persistent Hubble tension.

The O’Donnell Foundation committed $60 million to seed SMU’s new Energy Science, Innovation and Enterprise program and a named honors fund, with offerings set to begin in fall 2026.

Avance Biosciences opened a 75,000-square-foot GMP potency and cell-based assay center in northwest Houston to support vaccines and cell and gene therapies.